Treatment of fibrosis

US10106603B2 · kind B2 · utility

Assignees

• SINGAPORE HEALTH SERVICES PTE. LTD. · SG
• NATIONAL UNIVERSITY OF SINGAPORE · SG

Inventors

• Stuart Alexander Cook · Singapore, SG
• Sebastian Schaefer · Glückstadt, DE

Key dates

• Filing date: May 24, 2018
• Grant date: Oct 23, 2018
• Expiry date: May 24, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.